Spectrum of CD30+ Lymphoid Proliferations in the Eyelid. Lymphomatoid Papulosis, Cutaneous Anaplastic Large Cell Lymphoma, and Anaplastic Large Cell Lymphoma

Ophthalmology

Volumn 117, Issue 2, 2010, Pages 343-351

  Sanka, R Krishna ^a   Eagle Jr , Ralph C ^b   Wojno, Ted H ^a   Neufeld, Kenneth R ^c   Grossniklaus, Hans E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c Thomas Eye Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANAPLASTIC LYMPHOMA KINASE; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CEFDINIR; CIPROFLOXACIN; COTRIMOXAZOLE; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKERATIN 6; CYTOKERATIN 7; DEXAMETHASONE PLUS TOBRAMYCIN; DOXYCYCLINE; EPITHELIAL MEMBRANE ANTIGEN; FASCIN; FLUORODEOXYGLUCOSE F 18; LYMPHOCYTE ANTIGEN; PSEUDOMONIC ACID; SULTAMICILLIN; VIMENTIN;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CASE STUDY; CD4 LYMPHOCYTE COUNT; CHEMOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ERYTHEMA; EYE SWELLING; EYELID; EYELID DISEASE; EYELID EDEMA; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN LYMPHOMA; SMALL INTESTINE OBSTRUCTION; SOFT TISSUE; T LYMPHOCYTE; TREATMENT OUTCOME; VISION;

ADOLESCENT; ADULT; AGED, 80 AND OVER; ANTIGENS, CD30; EYELID NEOPLASMS; FATAL OUTCOME; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL; LYMPHOMATOID PAPULOSIS; MALE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 75149125051     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.07.013     Document Type: Article

References (36)

1. Droc C., Cualing H.D., and Kadin M.E. Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin. Cancer Control 14 (2007) 124-132
2. Assaf C., Hirsch B., Wagner F., et al. Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations. J Invest Dermatol 127 (2007) 1898-1904
3. Coupland S.E., Foss H.D., Assaf C., et al. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology 106 (1999) 2109-2120
4. LeBoit P.E. Lymphomatoid papulosis and cutaneous CD30+ lymphoma. Am J Dermatopathol 18 (1996) 221-235
5. Stein H., Mason D.Y., Gerdes J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 (1985) 848-858
6. Benharroch D., Meguerian-Bedoyan Z., Lamant L., et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91 (1998) 2076-2084
7. Kadin M.E. Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 5 suppl (1994) 25-30
8. Kadin M.E., Sako D., Berliner N., et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 68 (1986) 1042-1049
9. Fischer P., Nacheva E., Mason D.Y., et al. A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 72 (1988) 234-240
10. Le Beau M.M., Bitter M.A., Larson R.A., et al. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3 (1989) 866-870
11. Falini B. Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 114 (2001) 741-760
12. Amin H.M., and Lai R. Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood 110 (2007) 2259-2267
13. Bekkenk M.W., Geelen F.A., van Voorst Vader P.C., et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95 (2000) 3653-3661
14. DeCoteau J.F., Butmarc J.R., Kinney M.C., and Kadin M.E. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87 (1996) 3437-3441
15. Coupland S.E., Krause L., Delecluse H.J., et al. Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology 105 (1998) 1430-1441
16. Boulton J.E., Chesterton J.R., and McGibbon D.H. Symmetrical lymphomatoid papulosis masquerading as pyoderma chancriformis of the eyelids [letter]. Br J Ophthalmol 79 (1995) 391-392
17. Lemagne J.M., Croughs P., Roumanos N., and Maldague P. Lymphomatoid papulosis of the eyelid [in French]. J Fr Ophtalmol 10 (1987) 247-252
18. Ramaesh K., Monaghan H., Kemmett D., et al. Retinal vein occlusion in lymphomatoid papulosis. Eur J Ophthalmol 12 (2002) 542-546
19. Clarke B., Legodi E., Chrystal V., and Govender D. Systemic anaplastic large cell lymphoma presenting with conjunctival involvement. Arch Ophthalmol 121 (2003) 568-570
20. Mencia-Gutierrez E., Gutierrez-Diaz E., Salamanca J., and Martinez-Gonzalez M.A. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL). Int J Dermatol 45 (2006) 766-769
21. Hu F.R., Lin J.C., Chiang I.P., and Yeh K.H. T-cell malignant lymphoma with conjunctival involvement. Am J Ophthalmol 125 (1998) 717-719
22. Winhoven S.M., Murugesan S., and Coulson I.H. Solitary CD30+ anaplastic large cell lymphoma of the eyelid showing regression [letter]. Br J Ophthalmol 89 (2005) 385
23. Segal Z.I., Cohen I., Szvalb S., et al. Solitary extranodal anaplastic large cell lymphoma, Ki-1+, of the eyelid. Am J Ophthalmol 124 (1997) 105-107
24. Koreen I.V., Cho R.I., Frueh B.R., and Elner V.M. Primary cutaneous anaplastic large cell lymphoma of the medial canthus and orbit. Ophthal Plast Reconstr Surg 25 (2009) 63-65
25. Tanzi E., Edelman M., and Rosenbaum P.S. Ki-1-positive anaplastic large-cell lymphoma of the eyelid. Arch Ophthalmol 117 (1999) 955-958
26. Kempf W., Levi E., Kamarashev J., et al. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol 29 (2002) 295-300
27. Fan G., Kotylo P., Neiman R.S., and Braziel R.M. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease. Am J Clin Pathol 119 (2003) 199-204
28. Jang K.A., Choi J.C., and Choi J.H. Expression of cutaneous lymphocyte-associated antigen and TIA-1 by lymphocytes in pityriasis lichenoides et varioliformis acuta and lymphomatoid papulosis: immunohistochemical study. J Cutan Pathol 28 (2001) 453-459
29. de Bruin P.C., Beljaards R.C., van Heerde P., et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23 (1993) 127-135
30. Paulli M., Berti E., Boveri E., et al. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily. Hum Pathol 29 (1998) 1223-1230
31. Chiarle R., Podda A., Prolla G., et al. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. J Immunol 163 (1999) 194-205
32. Natkunam Y., Warnke R.A., Haghighi B., et al. Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases. J Cutan Pathol 27 (2000) 392-399
33. Chang S.E., Park I.J., Huh J., et al. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma. Br J Dermatol 142 (2000) 766-770
34. Suzuki R., Kagami Y., Takeuchi K., et al. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype. Blood 96 (2000) 2993-3000
35. Rassidakis G.Z., Jones D., Lai R., et al. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation. J Pathol 200 (2003) 240-248
36. Schiemann W.P., Pfeifer W.M., Levi E., et al. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood 94 (1999) 2854-2861